Spinal Cord Research Help
AboutCategoriesLatest ResearchContact
Subscribe
Spinal Cord Research Help

Making Spinal Cord Injury (SCI) Research Accessible to Everyone. Simplified summaries of the latest research, designed for patients, caregivers and anybody who's interested.

Quick Links

  • Home
  • About
  • Categories
  • Latest Research
  • Disclaimer

Contact

  • Contact Us
© 2025 Spinal Cord Research Help

All rights reserved.

  1. Home
  2. Research
  3. Immunology
  4. Rehabilitation and pharmacotherapy of neuromyelitis optica spectrum disorder: A case report

Rehabilitation and pharmacotherapy of neuromyelitis optica spectrum disorder: A case report

World Journal of Clinical Cases, 2021 · DOI: 10.12998/wjcc.v9.i16.3951 · Published: June 6, 2021

ImmunologyNeurologyRehabilitation

Simple Explanation

Neuromyelitis optica spectrum disorder (NMOSD) is an autoimmune condition affecting the central nervous system. It often shows up as inflammation of the optic nerve or spinal cord. This paper presents the case of a 45-year-old woman diagnosed with NMOSD who also had Sjogren's syndrome, spinal cord injury, and a blood clot in her leg. The patient was treated with strong medications and standard rehabilitation. After treatment, she could control her bladder and bowels, stand on her own, and walk a bit with a walker.

Study Duration
Not specified
Participants
A 45-year-old woman
Evidence Level
Case report

Key Findings

  • 1
    The patient with NMOSD, spinal cord injury, Sjogren's syndrome, and deep venous thrombosis showed considerable improvement after rehabilitation and pharmacotherapy.
  • 2
    Pharmacotherapy and standard rehabilitation treatment can improve the prognosis of NMSOD patients.
  • 3
    The patient experienced improvements in sitting balance, walking stability, gait, and execution of daily activities after rehabilitation.

Research Summary

This case report discusses a 45-year-old woman with NMOSD, Sjogren's syndrome, spinal cord injury, and deep venous thrombosis who underwent rehabilitation and pharmacotherapy. The patient's condition improved significantly after treatment, regaining the ability to sit, stand, walk independently, and control bodily functions. The findings suggest that pharmacotherapy combined with standardized rehabilitation can improve the prognosis for NMOSD patients.

Practical Implications

Improved NMOSD Management

Early diagnosis and treatment of NMOSD can help manage this recurrent and disabling disease.

Rehabilitation Benefits

Standardized rehabilitation training can reduce neuromotor dysfunction and improve activities of daily living.

Cautious Rehabilitation

It is crucial to avoid excessive fatigue during rehabilitation to minimize the risk of symptom aggravation and recurrence.

Study Limitations

  • 1
    [object Object]
  • 2
    [object Object]
  • 3
    [object Object]

Your Feedback

Was this summary helpful?

Back to Immunology